Liposcale for early and reliable diagnosis and prognosis of breast cancer patients

Liposcale Breast cancer

One of the key features of malignant tumour cells is that their energy metabolism is altered. However, in recent years, alterations in lipid metabolism have been described in some types of cancer. A study led by the team of Dr. Josep Gumà and Dr. Sandra Guaita from the Pere Virgili Health Research Institute (IISPV) and […]

Liposcale in Circulation

Liposcale in Circulation

Frequent consumption of nuts, an important component of plant-based diets, is associated with a 15% reduction in total cardiovascular disease (CVD) and a 23% reduction in CVD mortality. Although small studies have shown that supplementing the diet with nuts has a considerable effect on reducing dietary cholesterol in the short term, there is little information […]

Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test

malaltia cardiovascular ateromatosa

Patients with chronic kidney disease (CKD) have a high burden of atheromatous cardiovascular disease (ASCVD) that is not fully explained by traditional lipid parameters. A study published in the clinical Kidney journal, conducted in patients with chronic kidney disease, reveals that information on lipoprotein composition and subclass particle number using the Liposcale test could improve […]

Biosfer Teslab participates in a video of covid-19 research

Covid-19

Last week, in Biosfer Teslab, we participated in the video made as part of the URVGoals project, which shows different research being carried out at the URV with a common goal: to fight against the pandemic. The video shows eight research projects from all fields showing that the fight against covid-19 is totally transversal. In […]

Biosfer Teslab Collaborates in Cancer Studies

càncer

Metabolomics can help in the study of different cancers by analysing whether a particular type of tumour is characterised by the development of certain metabolites. To this aim, Biosfer Teslab collaborates directly with Josep Gumà, director of the Oncology Institute of Southern Catalonia, and together with the Higher Technical School of Engineering of the URV […]

Early molecular signature of Parkinson and dementia years before the diseases appear

NMR metabolomics could identify altered lipoprotein and protein glycosylation profiles in REM sleep behavior disorder (iRBD), the prodromal stage of Lewy-type synucleinopathies (LTS) -including Parkinson and dementia. NMR showed predictive power distinguishing future clinical outcome, being a useful tool for identifying short-term high-risk patients for conversion to parkinsonism or dementia. Here you can see the […]

The use of Liposcale® Test in Premature Cardiovascular disease

Last week, a new paper, which evaluates the use of the Liposcale® test as a predictor of premature cardiovascular disease (PRESARV-SEA Study), was published. Beyond levels of LDL-C, results reported in the article support the relevance of LDL cholesterol composition and size on premature cardiovascular disease progression and its potential as a new biomarker for […]

Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia

Dr. Amor and collaborators have published a new article in the Diabetes Research and Clinical Practice journal using our plasma metabolomics analysis. The aim of the study was to evaluate the role of plasma metabolomics in atherosclerosis according to the presence of type 1 diabetes (T1D) or previous preeclampsia. They have concluded that plasma metabolomics […]

Biosfer Teslab’s Internacionalization

Biosfer Teslab has received from the Cambra de comerç de Reus an Xpande Digital 2020:  a competitive call for international digitization! This action is co-financed with FEDER funds (European Regional Development Fund) from the European Union. This call is aimed to support the digitization of SMEs, as part of its international strategy, whose main objective […]